Our previous study reported that the expression of KRT19 was upregulated in various breast cancer cell lines (i.e., MDA-MB231, MCF7) and was downregulated in highly aggressive cancer stem-like cells [46]. This evidence concerns the gene KRT19 and breast carcinoma.